We are live on !
Find out more
PAP
Persistent Asset Partners Portfolio holdings
AUM
$335M
Turnover
79.96%
1-Year Est. Return
275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
(+25%)
Cap. Flow
-$37.3M
Cap. Flow % of AUM
Cap. Flow %
-11.13%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$16M |
| 2 |
STMicroelectronics
STM
|
+$13.6M |
| 3 |
Amphenol
APH
|
+$10.9M |
| 4 |
Seagate
STX
|
+$7.07M |
| 5 |
Ford
F
|
+$6.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$18.4M |
| 2 |
Lumentum
LITE
|
+$14.5M |
| 3 |
AXT Inc
AXTI
|
+$13.3M |
| 4 |
Tower Semiconductor
TSEM
|
+$11.9M |
| 5 |
Micron Technology
MU
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.35% |
| 2 | Healthcare | 29.66% |
| 3 | Financials | 6.33% |
| 4 | Miscellaneous | 6.14% |
| 5 | Consumer Discretionary | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Charles River Laboratories
CRL
$14.3B
| $267K | 0.08% |
1,177
-1,466
| -55% | -$261K |
2025 Q4
2 quarters
|
|
177
Cellectar Biosciences
CLRB
$10.6M
| $258K | 0.08% |
+92,983
| New | +$260K |
2026 Q2
0 quarters
|
|
178
CALL
Monte Rosa Therapeutics
GLUE
$909M
| $258K | 0.08% |
+434
| New | +$8.2K |
2026 Q2
0 quarters
|
|
179
Tango Therapeutics
TNGX
$3.97B
| $258K | 0.08% |
8,238
-14,878
| -64% | -$368K |
2026 Q1
1 quarter
|
|
180
BioNTech
BNTX
$22.4B
| $256K | 0.08% |
+2,755
| New | +$259K |
2026 Q2
0 quarters
|
|
181
DBV Technologies S.A. American Depositary Shares
DBVT
$564M
| $256K | 0.08% |
15,630
+4,238
| +37% | +$80K |
2025 Q4
2 quarters
|
|
182
Huya Inc
HUYA
$516M
| $254K | 0.08% |
110,327
+88,054
| +395% | +$250K |
2025 Q4
2 quarters
|
|
183
Calumet Specialty Products
CLMT
$4.88B
| $253K | 0.08% |
+7,037
| New | +$237K |
2026 Q2
0 quarters
|
|
184
iRhythm Holdings
IRTC
$3.61B
| $253K | 0.08% |
+2,129
| New | +$247K |
2026 Q2
0 quarters
|
|
185
Harmony Biosciences
HRMY
$2.19B
| $249K | 0.07% |
6,843
-16,705
| -71% | -$527K |
2025 Q3
3 quarters
|
|
186
Icon
ICLR
$13B
| $249K | 0.07% |
1,431
-1,982
| -58% | -$252K |
2025 Q4
2 quarters
|
|
187
CALL
Vaxcyte
PCVX
$10B
| $249K | 0.07% |
135
| – | – |
2026 Q1
1 quarter
|
|
188
NewAmsterdam Pharma
NAMS
$2.45B
| $247K | 0.07% |
+7,284
| New | +$240K |
2026 Q2
0 quarters
|
|
189
Royal Caribbean
RCL
$75.4B
| $247K | 0.07% |
+777
| New | +$217K |
2026 Q2
0 quarters
|
|
190
CALL
Bristol-Myers Squibb
BMY
$120B
| $244K | 0.07% |
+1,535
| New | +$88.1K |
2026 Q2
0 quarters
|
|
191
Regal Rexnord
RRX
$10.5B
| $243K | 0.07% |
+1,019
| New | +$213K |
2026 Q2
0 quarters
|
|
192
United Parks & Resorts
PRKS
$1.46B
| $237K | 0.07% |
+4,965
| New | +$193K |
2026 Q2
0 quarters
|
|
193
Medtronic
MDT
$119B
| $236K | 0.07% |
3,012
-234
| -7% | -$18.9K |
2025 Q4
2 quarters
|
|
194
CALL
Corbus Pharmaceuticals
CRBP
$86.3M
| $235K | 0.07% |
1,615
+1,323
| +453% | +$12.5K |
2026 Q1
1 quarter
|
|
195
Alliance Laundry Holdings
ALH
$4.24B
| $232K | 0.07% |
+8,759
| New | +$219K |
2026 Q2
0 quarters
|
|
196
Cartesian Therapeutics
RNAC
$184M
| $231K | 0.07% |
+22,191
| New | +$164K |
2026 Q2
0 quarters
|
|
197
Foghorn Therapeutics
FHTX
$111M
| $229K | 0.07% |
46,872
+228
| +0.5% | +$1.01K |
2025 Q3
3 quarters
|
|
198
Rigel Pharmaceuticals
RIGL
$873M
| $228K | 0.07% |
+5,821
| New | +$180K |
2026 Q2
0 quarters
|
|
199
Arcutis Biotherapeutics
ARQT
$4.01B
| $227K | 0.07% |
+8,657
| New | +$202K |
2026 Q2
0 quarters
|
|
200
Hyatt Hotels
H
$16.2B
| $223K | 0.07% |
+1,152
| New | +$202K |
2026 Q2
0 quarters
|
|
Similar funds
JWM
PI
TFA
SIM
OWM
SS
BIA
TODC
Persistent Asset Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.
- Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
- Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
- Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
- Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
- Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
- Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
- Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.
Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.